<?xml version="1.0" encoding="UTF-8"?>
<p id="Par37">This is a phase II/III, multi-centre, prospective open-label two-arm randomised superiority clinical trial of standard care versus azithromycin with standard care alone for those presenting to hospital with COVID-19 symptoms who are not admitted at initial presentation (Fig. 
 <xref rid="Fig1" ref-type="fig">1</xref>). The study procedures are outlined in Table 
 <xref rid="Tab1" ref-type="table">1</xref>. 
</p>
